ACCME was surprised by the vociferous response to its June 11 call for comment on several proposals, including one that would establish a “pharma-free” label for accredited CME and another that would designate activities to be free of teachers or authors that did promotional work.
For the past three years, my colleagues and I in the Johnson & Johnson corporate communication group have been taking steps to get the company more involved with the social web.
A new service from Wolters Kluwer Health integrates several of the marketing research firm’s data points into a single source, offering financial analysts and brand managers a new forecasting capability.
The Supreme Court will not take on a New Hampshire data ban originally enacted in 2006, overturned 10 months later by a district court, and then reinstated by a federal appeals court last November.
Vantage Point: Should prescribing behavior be private?
What data about healthcare provider behavior should be private? Given the overall increases in healthcare costs, should data about individual physicians be subject to the same heightened levels of privacy we apply to patients?
PhRMA has committed to finding $80 billion in savings on drugs sold in the US over 10 years, including selling drugs at half-price to seniors in the Medicare Part D “donut hole” coverage gap.
DazMedia hopes to leverage its interactive work with Bayer on Betaseron, an MS treatment, into other product and condition areas for a new website: Real World Health.
At a recent conference, I told two perplexed-looking FDA attendees that I thought pharma has a distinct advantage with social media, because we’re used to marketing with boundaries, and social-media rules and FDA guidelines are actually quite similar.
Agency Business briefs
July 15, 2009
4:00 am
Featuring news from imc² health & wellness, MicroMass, Interpublic Group, Kluster and Sudler & Hennessey